Verastem Oncology Company Contacts

Verastem Oncology

https://www.verastem.com
Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that... Read More
Contacts

Country

United States

City

Needham

Headquarters

Needham, Massachusetts

Profile

Founded

2010

Industry

Biotechnology Research

Size

51 - 200

Specialties

Oncology, pharmaceutical, hematology, biotechnology, cancer, clinical trials, cancer research, blood cancer, CLL, Lymphoma, NHL, T Cell Lymphoma

Funding

Total Rounds

10

Last Round

Tue Jul 23 2024

Last Round Series

Post IPO equity

Last Round Raised

$ 55,000,000